SW
IMGN

SteelPeak Wealth’s Immunogen Inc IMGN Stock Holding History

SteelPeak Wealth’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,000
Closed -$58K – 372
2020
Q3 		$58K Hold
16,000
– – 0.01% 282
2020
Q2 		$74K Hold
16,000
– – 0.01% 252
2020
Q1 		$55K Hold
16,000
– – 0.01% 230
2019
Q4 		$82K Buy
+16,000
New +$54.3K 0.01% 252

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SteelPeak Wealth's IMGN Position: Q4 2020 in Review

SteelPeak Wealth sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 16,000 shares — an estimated $58K sold.

SteelPeak Wealth first reported a position in IMGN in Q4 2019 and held it in 4 quarters. The position peaked at $82K in Q4 2019. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

  • SteelPeak Wealth reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
  • SteelPeak Wealth sold 16,000 Immunogen Inc shares in Q4 2020, an estimated $58K.
  • SteelPeak Wealth first reported a position in Immunogen Inc in Q4 2019 and held it in 4 quarters.
  • SteelPeak Wealth's Immunogen Inc position peaked at $82K in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on SteelPeak Wealth's 13F filing for Q4 2020, filed 4 Feb 2021.